Skip to main content
. 2005 Mar 15;9(3):R200–R210. doi: 10.1186/cc3495

Table 2.

Study endpoints

Characteristic Remifentanil (n = 57) Comparator (n = 48) P
Number (%) of patients extubated 29 (51%) 16 (33%)
Time from start of study drugs to weaning (h) 83.0 98.0 0.523
 Difference (95% CI) -15.0 (-61.8 to 31.8)
Time from start of study drugs to extubation(h) 94.0 147.5 0.033
 Difference (95% CI) -53.5 (-111.4 to 4.4)
Time from weaning time until extubation (h) 0.9 27.5 <0.001
 Difference (95% CI) -26.6 (-40.8 to -12.4)
Time from start of study drugs until ICU discharge (h) 187.3 209.8 0.326
 Difference (95% CI) -22.5 (-201.5 to 156.5)

Point estimates are 75th centiles. CI, confidence interval.